Anti-SARS Spike Protein (18951)
- -
- -
Antibody DetailsProduct DetailsReactivity Species Sars Host Species Rabbit Immunogen Synthetic peptide corresponding to amino acids at the center of SARS-CoV spike protein. Product Concentration 1.0 mg/ml Formulation PBS, 0.02% sodium azide. State of Matter Liquid Product Preparation Purified by peptide immuno-affinity chromatography Storage and Handling This antibody is stable for at least one (1) year at -20°C. Country of Origin USA Shipping Next Day 2-8°C Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Rabbit Polyclonal Antibody specific to SARS Spike Protein Background Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus
referred to as SARS-associated coronavirus (SARS-CoV). SARS was first reported in Asia in
February 2003. Over the next few months, the illness spread to more than two dozen countries in
North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was
contained. SARS-CoV is transmitted from person to person by close personal contact such as
via respiratory droplets produced when an infected person coughs or sneezes. The genomes of
these viruses are positive-stranded RNA approximately 27-31kb long. SARS-CoV spike (S)
protein has two major biological functions: 1) mediating receptor (angiotensin converting enzyme
2, ACE2) binding and membrane fusion; 2) inducing neutralizing antibody responses. Antigen DetailsResearch Area Infectious Disease References & CitationsTechnical Protocols |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
